Design and therapeutic applications of cyclotides

Future Medicinal Chemistry

Volumn 1, Issue 9, 2009, Pages 1613-1622

  Daly, Norelle L ^a   Craik, David J ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; CYCLOTIDE; PROTEINASE;

CYTOTOXICITY; DRUG ACTIVITY; DRUG DESIGN; DRUG MECHANISM; DRUG POTENCY; DRUG SYNTHESIS; ENZYME INHIBITION; FOOT AND MOUTH DISEASE; INSECTICIDAL ACTIVITY; NONHUMAN; PLANT CELL CULTURE; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN EXPRESSION; SHORT SURVEY; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS; CYCLOTIDES; DRUG DESIGN; HUMANS; NEOPLASMS; PROTEIN ENGINEERING;

EID: 77953454570     PISSN: 17568919     EISSN: None     Source Type: Journal    
DOI: 10.4155/fmc.09.129     Document Type: Short Survey

References (68)

1. Trabi M, Craik DJ. Circular proteins - no end in sight. Trends Biochem. Sci. 27, 132-138 (2002).
2. Craik DJ. Seamless proteins tie up their loose ends. Science 311, 1563-1564 (2006).
3. Craik DJ, Daly NL, Mulvenna J, Plan MR, Trabi M. Discovery, structure and biological activities of the cyclotides. Curr. Prot. Pept. Sci. 5, 297-315 (2004).
4. Jennings C, West J, Waine C, Craik D, Anderson M. Biosynthesis and insecticidal properties of plant cyclotides: the cyclic knotted proteins from Oldenlandia affinis. Proc. Natl Acad. Sci. USA 98, 10614-10619 (2001).
5. Jennings CV, Rosengren KJ, Daly NL et al. Isolation, solution structure and insecticidal activity of kalata B2, a circular protein with a twist: do Möbius strips exist in nature? Biochemistry 44, 851-860 (2005).
6. Craik DJ. Circling the enemy: cyclic proteins in plant defence. Trends Plant Sci. 14, 328-335 (2009).
7. Craik DJ, Daly NL, Bond T, Waine C. Plant cyclotides: a unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. J. Mol. Biol. 294, 1327-1336 (1999).
8. Craik DJ, Cemazar M, Daly NL. The chemistry and biology of cyclotides. Curr. Opin. Drug Discov. Develop. 10, 176-184 (2007).
9. Colgrave ML, Craik DJ. Thermal, chemical and enzymatic stability of the cyclotide kalata B1: the importance of the cyclic cystine knot. Biochemistry 43, 5965-5975 (2004).
10. Gran L, Sletten K, Skjeldal L. Cyclic peptides from Oldenlandia affinis DC. Molecular and biological properties. Chem. Biodivers. 5, 2014-2022 (2008).
11. Craik DJ, Simonsen S, Daly NL. The cyclotides: novel macrocyclic peptides as scaffolds in drug design. Curr. Opin. Drug Discov. Devel. 5, 251-260 (2002).
12. Craik DJ, Cemazar M, Daly NL. The cyclotides and related macrocyclic peptides as scaffolds in drug design. Curr. Opin. Drug Discov. Develop. 9, 251-260 (2006).
13. Craik DJ, Clark RJ, Daly NL. Potential therapeutic applications of the cyclotides and related cystine knot mini-proteins. Expert Opin. Investig. Drugs 16, 595-604 (2007).
14. Gran L. Oxytocic principles of Oldenlandia affinis. Lloydia 36, 174-178 (1973).
15. Gran L. Isolation of oxytocic peptides from Oldenlandia affinis by solvent extraction of tetraphenylborate complexes and chromatography on sephadex LH-20. Lloydia 36, 207-208 (1973).
16. Gran L. On the effect of a polypeptide isolated from "Kalata- Kalata" (Oldenlandia affinis DC) on the oestrogen dominated uterus. Acta Pharmacol. Toxicol. 33, 400-408 (1973).
17. Saether O, Craik DJ, Campbell ID et al. Elucidation of the primary and threedimensional structure of the uterotonic polypeptide kalata B1. Biochemistry 34, 4147-4158 (1995).
18. Schöpke T, Hasan Agha MI, Kraft R, Otto A, Hiller K. Hämolytisch aktive komponenten aus Viola tricolor L. und Viola arvensis Murray. Sci. Pharm. 61, 145-153 (1993).
19. Gustafson KR, Sowder RCI, Henderson LE et al. Circulins A and B: novel HIVinhibitory macrocyclic peptides from the tropical tree Chassalia parvifolia. J. Am. Chem. Soc. 116, 9337-9338 (1994).
20. Witherup KM, Bogusky MJ, Anderson PS et al. Cyclopsychotride A, a biologically active, 31-residue cyclic peptide isolated from Psychotria longipes. J. Nat. Prod. 57, 1619-1625 (1994).
21. Gustafson KR, Walton LK, Sowder RCI et al. New circulin macrocyclic polypeptides from Chassalia parvifolia. J. Nat. Prod. 63, 176-178 (2000).
22. Hallock YF, Sowder RCI, Pannell LK et al. Cycloviolins A-D, anti-HIV macrocyclic peptides from Leonia cymosa. J. Org. Chem. 65, 124-128 (2000).
23. Göransson U, Luijendijk T, Johansson S, Bohlin L, Claeson P. Seven novel macrocyclic polypeptides from Viola arvensis. J. Nat. Prod. 62, 283-286 (1999).
24. Gruber CW, Elliott AG, Ireland DC et al. Distribution and evolution of circular miniproteins in flowering plants. Plant Cell 20, 2471-2483 (2008).
25. Heitz A, Hernandez JF, Gagnon J et al. Solution structure of the squash trypsin inhibitor MCoTI-II. A new family for cyclic knottins. Biochemistry 40, 7973-7983 (2001).
26. Felizmenio-Quimio ME, Daly NL, Craik DJ. Circular proteins in plants: solution structure of a novel macrocyclic trypsin inhibitor from Momordica cochinchinensis. J. Biol. Chem. 276, 22875-22882 (2001).
27. Hernandez JF, Gagnon J, Chiche L et al. Squash trypsin inhibitors from Momordica cochinchinensis exhibit an atypical macrocyclic structure. Biochemistry 39, 5722-5730 (2000).
28. Chiche L, Heitz A, Gelly JC et al. Squash inhibitors: from structural motifs to macrocyclic knottins. Curr. Prot. Pept. Sci. 5, 341-349 (2004).
29. Gracy J, Le-Nguyen D, Gelly JC et al. KNOTTIN: the knottin or inhibitor cystine knot scaffold in 2007. Nucleic Acids Res. 36, D314-319 (2008).
30. Wang CK, Kaas Q, Chiche L, Craik DJ. CyBase: a database of cyclic protein sequences and structures, with applications in protein discovery and engineering. Nucleic Acids Res. 36, D206-D210 (2008).
31. Göransson U, Sjogren M, Svangard E, Claeson P, Bohlin L. Reversible antifouling effect of the cyclotide cycloviolacin O2 against barnacles. J. Nat. Prod. 67, 1287-1290 (2004).
32. Tam JP, Lu YA, Yang JL, Chiu KW. An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides. Proc. Natl Acad. Sci. USA 96, 8913-8918 (1999).
33. Lindholm P, Göransson U, Johansson S et al. Cyclotides: a novel type of cytotoxic agents. Mol. Cancer Ther. 1, 365-369 (2002).
34. Svangard E, Göransson U, Hocaoglu Z et al. Cytotoxic cyclotides from Viola tricolor. J. Nat. Prod. 67, 144-147 (2004).
35. Plan MR, Saska I, Cagauan AG, Craik DJ. Backbone cyclised peptides from plants show molluscicidal activity against the rice pest Pomacea canaliculata (golden apple snail). J. Agric. Food Chem. 56, 5237-5241 (2008).
36. Colgrave ML, Kotze AC, Huang YH et al. Cyclotides: natural, circular plant peptides that possess significant activity against gastrointestinal nematode parasites of sheep. Biochemistry 47, 5581-5589 (2008).
37. Colgrave ML, Kotze AC, Kopp S et al. Anthelmintic activity of cyclotides: in vitro studies with canine and human hookworms. Acta Trop. 109, 163-166 (2009).
38. Wang CK, Hu SH, Martin JL et al. Combined X-ray and NMR analysis of the stability of the cyclotide cystine knot fold that underpins its insecticidal activity and potential use as drug scaffold. J. Biol. Chem. (2009).
39. Isaacs NW. Cystine knots. Curr. Opin. Struct. Biol. 5, 391-395 (1995).
40. Craik DJ, Daly NL, Waine C. The cystine knot motif in toxins and implications for drug design. Toxicon 39, 43-60 (2001).
41. Daly NL, Love S, Alewood PF, Craik DJ. Chemical synthesis and folding pathways of large cyclic polypeptides: studies of the cystine knot polypeptide kalata B1. Biochemistry 38, 10606-10614 (1999).
42. Skjeldal L, Gran L, Sletten K, Volkman BF. Refined structure and metal binding site of the kalata B1 peptide. Arch. Biochem. Biophys. 399, 142-148 (2002).
43. Rosengren KJ, Daly NL, Plan MR, Waine C, Craik DJ. Twists, knots and rings in proteins. Structural definition of the cyclotide framework. J. Biol. Chem. 278, 8606-8616 (2003).
44. Sze SK, Wang W, Meng W et al. Elucidating the structure of cyclotides by partial acid hydrolysis and LC-MS/MS analysis. Anal Chem 81, 1079-1088 (2009).
45. Combelles C, Gracy J, Heitz A, Craik DJ, Chiche L. Structure and folding of disulfiderich miniproteins: insights from molecular dynamics simulations and MM-PBSA free energy calculations. Proteins 73, 87-103 (2008).
46. Shehu A, Kavraki LE, Clementi C. Unfolding the fold of cyclic cysteine-rich peptides. Prot. Sci. 17, 482-493 (2008).
47. Daly NL, Clark RJ, Plan MR, Craik DJ. Kalata B8, a novel antiviral circular protein, exhibits conformational flexibility in the cystine knot motif. Biochem. J. 393, 619-626 (2006).
48. Gunasekera S, Foley FM, Clark RJ et al. Engineering stabilized vascular endothelial growth factor-A antagonists: synthesis, structural characterization and bioactivity of grafted analogues of cyclotides. J. Med. Chem. 51, 7697-7704 (2008).
49. Cheek S, Krishna SS, Grishin NV. Structural classification of small, disulfide-rich protein domains. J. Mol. Biol. 359, 215-237 (2006).
50. Ireland DC, Colgrave ML, Nguyencong P, Daly NL, Craik DJ. Discovery and characterization of a linear cyclotide from Viola odorata: implications for the processing of circular proteins. J. Mol. Biol. 357, 1522-1535 (2006).
51. Heitz A, Avrutina O, Le-Nguyen D et al. Knottin cyclization: impact on structure and dynamics. BMC Struct. Biol. 8, 54 (2008).
52. Simonsen SM, Sando L, Rosengren KJ et al. Alanine scanning mutagenesis of the prototypic cyclotide reveals a cluster of residues essential for bioactivity. J. Biol. Chem. 283, 9805-9813 (2008).
53. Svangard E, Burman R, Gunasekera S et al. Mechanism of action of cytotoxic cyclotides: cycloviolacin O2 disrupts lipid membranes. J. Nat. Prod. 70, 643-647 (2007).
54. Shenkarev ZO, Nadezhdin KD, Sobol VA et al. Conformation and mode of membrane interaction in cyclotides. Spatial structure of kalata B1 bound to a dodecylphosphocholine micelle. FEBS J. 273, 2658-2672 (2006).
55. Huang YH, Colgrave ML, Daly NL et al. The biological activity of the prototypic cyclotide Kalata B1 is modulated by the formation of multimeric pores. J. Biol. Chem. 284(31), 20699-20707 (2009).
56. Greenwood KP, Daly NL, Brown DL, Stow JL, Craik DJ. The cyclic cystine knot miniprotein MCoTI-II is internalized into cells by macropinocytosis. Int. J. Biochem. Cell Biol. 39, 2252-2264 (2007).
57. Clark RJ, Daly NL, Craik DJ. Structural plasticity of the cyclic-cystine-knot framework: implications for biological activity and drug design. Biochem. J. 394, 85-93 (2006).
58. Thongyoo P, Roque-Rosell N, Leatherbarrow RJ, Tate EW. Chemical and biomimetic total syntheses of natural and engineered MCoTI cyclotides. Org. Biomol. Chem. 6, 1462-1470 (2008). It is also the first report of an inhibitor of the foot and mouth 3C protease.
59. Kolmar H. Alternative binding proteins: Biological activity and therapeutic potential of cystine-knot miniproteins. FEBS J. 275, 2684-2690 (2008).
60. Kimura RH, Tran A-T, Camarero JA. Biosynthesis of the cyclotide kalata B1 by using protein splicing. Angew. Chem. Int. Ed. Engl. 118, 987-990 (2006).
61. Camarero JA, Kimura RH, Woo Y-H, Shekhtman A, Cantor J. Biosynthesis of a fully functional cyclotide inside living bacterial cells. ChemBioChem 8, 1363-1366 (2007).
62. Antos JM, Popp MW, Ernst R et al. A straight path to circular proteins. J. Biol. Chem. 284, 16028-16036 (2009).
63. Lee J, McIntosh J, Hathaway BJ, Schmidt EW. Using marine natural products to discover a protease that catalyzes peptide macrocyclization of diverse substrates. J. Am. Chem. Soc. 131, 2122-2124 (2009).
64. Seydel P, Gruber CW, Craik DJ, Dörnenburg H. Formation of cyclotides and variations in cyclotide expression in Oldenlandia affinis suspension cultures. Appl. Microbiol. Biotechnol. 77, 275-284 (2007).
65. Dörnenburg H, Frickinger P, Seydel P. Plant cell-based processes for cyclotides production. J. Biotechnol. 135, 123-126 (2008).
66. Dörnenburg H. Plant cell culture technologyharnessing a biological approach for competitive cyclotides production. Biotechnol. Lett. 30, 1311-1321 (2008).
67. Saska I, Gillon AD, Hatsugai N et al. An asparaginyl endopeptidase mediates in vivo protein backbone cyclisation. J. Biol. Chem. 282, 29721-29728 (2007).
68. Gillon AD, Saska I, Jennings CV et al. Biosynthesis of circular proteins in plants. Plant J. 53, 505-515 (2008).